UA96003C2 - PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2 - Google Patents

PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2

Info

Publication number
UA96003C2
UA96003C2 UAA200907977A UAA200907977A UA96003C2 UA 96003 C2 UA96003 C2 UA 96003C2 UA A200907977 A UAA200907977 A UA A200907977A UA A200907977 A UAA200907977 A UA A200907977A UA 96003 C2 UA96003 C2 UA 96003C2
Authority
UA
Ukraine
Prior art keywords
aib8
hglp
pharmaceutical composition
analogues
peptide
Prior art date
Application number
UAA200907977A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Чжен Ксин Донг
Роллан Шериф-Шейкх
Риголь Хосе-Антонио Кордеро
Миравете Ресуррексион Аллоса
Фредерик Лакомб
Маэстре Мария Долорес Тобалина
Original Assignee
Ипсен Фарма С.А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ипсен Фарма С.А.С. filed Critical Ипсен Фарма С.А.С.
Publication of UA96003C2 publication Critical patent/UA96003C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is directed to peptide analogues of glucagon-Iike peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues.
UAA200907977A 2006-12-29 2007-12-31 PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2 UA96003C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19671106P 2006-12-29 2006-12-29

Publications (1)

Publication Number Publication Date
UA96003C2 true UA96003C2 (en) 2011-09-26

Family

ID=42260494

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200907977A UA96003C2 (en) 2006-12-29 2007-12-31 PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2

Country Status (2)

Country Link
UA (1) UA96003C2 (en)
ZA (1) ZA200904725B (en)

Also Published As

Publication number Publication date
ZA200904725B (en) 2010-04-28

Similar Documents

Publication Publication Date Title
WO2009035540A3 (en) Analogues of exendin-4 and exendin-3
WO2009007714A3 (en) Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour
MX2009012675A (en) Reconstituted surfactants having improved properties.
WO2005058252A3 (en) Glp-1 pharmaceutical compositions
MY146969A (en) Dpp iv inhibitor formulations
HK1088840A1 (en) Stable analogs of glp-1 glp-1
PH12014500922A1 (en) Insulinotropic peptide derivative wherein its n-terminal amino acid is modified
HK1129581A1 (en)
TW200740456A (en) GLP-1 pharmaceutical compositions
TN2009000099A1 (en) Reconstituted surfactants having improved properties
UA96308C2 (en) Glucagon receptor antagonist compounds, composition comprising such compounds and use thereof
UA95235C2 (en) Glucagon-like-peptide-2 (glp-2) analogues
MX2007005521A (en) Stable formulations of insulinoptropic peptides.
WO2004074315A3 (en) Analogues of glp-1
NO20074823L (en) Rasagilin formulations with improved content uniformity
MY158106A (en) Inhibitors of e1 activating enzymes
MX2009005460A (en) (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs.
EA201001801A1 (en) AGONISTS OF MIXED ACTION ON THE BASIS OF GLUCI-DEPENDENT INSULINOTROPIC PEPTIDE FOR THE TREATMENT OF DISTURBANCES OF MATERIAL EXCHANGE AND OBESITY
PL1940381T3 (en) Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate
BRPI0509074A (en) pharmaceutical compositions comprising thyroid receptor agonists
MX2011007101A (en) Protein hydrolysate compositions having enhanced cck releasing ability.
MY148915A (en) An extended-release composition comprising a somatostatin derivative in microparticles
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
TW200730190A (en) New combination to treat liver fibrosis
MX2009006942A (en) Glp-1 pharmaceutical compositions.